Log in

M&ABusinessLine

AstraZeneca Pharma India inks agreement with Strand Life Sciences to explore healthcare collaboration

Positive+33

GreyOak summary

AstraZeneca Pharma India Ltd signed a letter of intent with Strand Life Sciences Pvt Ltd to explore healthcare collaboration opportunities in India. Strand Life Sciences is a genomics research and diagnostics company and a subsidiary of Reliance Industries Ltd. The company clarified that this is not a related party transaction.

What it affects

  • Signed LoI to explore healthcare collaboration.Rolling sentiment Positive +37

  • HealthcarePositive +33

    Collaboration opportunities being explored.Rolling sentiment Positive +37

Source

Read the original at BusinessLine

More AstraZeneca Pharma India news

All AstraZeneca Pharma India news →

We use cookies

Essential cookies keep GreyOak secure and functional. Optional cookies help improve your experience and platform performance. You can update your preferences anytime.

Cookie Policy